Form D · Biotechnology
Yecuris Corp
Portland, OR · CIK 0001468594
Offering snapshot reported Jul 17, 2009 · SEC filing
- Reported sold
- $1.25M Offering amount: $1.25M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1.25M Reported outside-investor minimum
- First sale
- Jun 26, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 17, 2009 | Initial | $1,250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-132878
Source: Form D, filed Jul 17, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Bial | Executive |
| Markus Grompe | Director, Executive, Promoter |
| Andrew Parkinson | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Mail Code L 321 3181 Sw Sam Jackson Park Road
Portland, OR, 97239
Portland, OR, 97239